Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Computer Model Identifies RNA Splicing Enhancers

By Biotechdaily staff writers
Posted on 25 Jul 2002
Researchers have found a way to predict which mutations in a gene's exons, those sections of the RNA which code for proteins, are likely to cause the exons to be skipped by the splicing machinery, which typically results in inactivation of the gene's product and can lead to disease. More...
This discovery was reported July 11, 2002, in the online journal Science Express.

Messenger RNA (mRNA) molecules contain strings of genetic material called exons, which code for proteins, and introns, which do not. Introns are removed from mRNA by a splicing mechanism that joins exons together. RNA splicing determines which segments of the gene end up being expressed and which do not.

The purpose of the study carried out at the Massachusetts Institute of Technology (MIT, Cambridge, USA; www.mit.edu) was to identify exonic splicing enhancers (ESEs). These are short RNA sequences that, when present in the exons of a human gene, enhance the splicing of the exons and thereby increase the proportion of mRNAs that contain them.

A computational method was developed, called RESCUE-ESE, that predicts which sequences have ESE activity by statistical analysis of exon-intron and splice site composition. When large datasets of human gene sequences were used, this method identified ten predicted ESE motifs. Representatives of all ten motifs were found to possess enhancer activity in vivo, whereas point mutants of these sequences exhibited sharply reduced activity.

"We developed a computational method to predict which sequences would function as ESEs, and then did experiments to test these predictions and found that all of the sequences predicted to function as splicing enhancers did indeed have this activity,” said senior author Dr. Christopher Burge, assistant professor in the biology department at MIT. "Eventually, we hope to be able to fully understand and model the process by which exons and introns are identified by the human RNA splicing machinery.”




Related Links:
MIT

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Manual Pipetting Aid
Pipette Controllers macro
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.